Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Institut De Recherche International Servier |
---|---|
Information provided by: | Servier |
ClinicalTrials.gov Identifier: | NCT00202592 |
The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children
Condition | Intervention | Phase |
---|---|---|
Hypertension |
Drug: Perindopril |
Phase II |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Safety and Effects on Blood Pressure of Daily Dose 0.025 to 0.135 Milligram Per Kilogram of S90625 a Paediatric Formulation of Perindopril, in Hypertensive Children - 24 Months |
Ages Eligible for Study: | 30 Months to 17 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Patrick Niaudet, Pr | + 33 1 44 49 44 44 |
France | |
Hôpital Necker Enfants Malades | Recruiting |
Paris, France | |
Contact: Patrick Niaudet, Pr + 33 1 44 49 44 44 |
Study Chair: | Patrick Niaudet, Pr | Hôpital Necker Enfants Malades, Paris, France |
Study ID Numbers: | CL2-90652-002 |
Study First Received: | September 12, 2005 |
Last Updated: | September 12, 2005 |
ClinicalTrials.gov Identifier: | NCT00202592 History of Changes |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Perindopril Vascular Diseases Angiotensin-Converting Enzyme Inhibitors Cardiovascular Agents |
Antihypertensive Agents Protease Inhibitors Hypertension |
Perindopril Molecular Mechanisms of Pharmacological Action Therapeutic Uses Vascular Diseases Angiotensin-Converting Enzyme Inhibitors Enzyme Inhibitors |
Cardiovascular Diseases Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions Protease Inhibitors Hypertension |